You can buy or sell Sesen Bio and other stocks, options, ETFs, and crypto commission-free!
Sesen Bio, Inc. engages in designing, engineering, and developing of targeted protein therapeutics. It offers the Vicinium and Proxinium which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. Read More The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. The listed name for SESN is Sesen Bio, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 10, Pre-Market